See also this year's filing and all EDGAR filings for this company.
PDF Report 0001072379_2023_Northwest_Biotherapeutics_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'00200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - Calc 2': 2, '00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)': 13}} |
Graph
Absolute values for 0001072379, Northwest Biotherapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 9,425,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 626,000 |
| 2 | PropertyPlantAndEquipmentNet | 13,418,000 |
| 3 | remainder_Assets | 7,854,000 |
| 4 | LiabilitiesCurrent | 126,005,000 |
| 5 | LiabilitiesNoncurrent | 10,361,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 37,270,683 |
| 9 | ResearchAndDevelopmentExpense | 36,776,843 |
| 10 | remainder_Expenses | 1,175,693 |
| 11 | remainder_Revenues | 1,616,577 |
| 12 | remainder_NetIncome | -38,256,965 |
| 13 | remainder_ComprehensiveNetIncome | 672,480 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 31,323,000 |
| 1 | Liabilities | 136,366,000 |
| 2 | Expenses | 75,223,219 |
| 3 | Revenues | 1,616,577 |
| 4 | StockholdersEquity | -105,043,000 |
| 5 | NetIncome | -111,863,607 |
| 6 | ComprehensiveNetIncome | -111,527,367 |
| 7 | BaseVar | 141,729,120 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -4.06 |
| 9 | EconomicCapitalRatio | 0.377 |
Edgar->Model Mapping
Feature Distribution
Change over Time
